Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewed
Inhibition of BRN2 in Melanoma Reverses Anoikis Resistance and Sensitizes Cells to Killing by Vemurafenib
Hannah M. Neuendorf, Xie He, Mark N. Adams…·Glen M. Boyle
This paper shows that inhibiting BRN2 in melanoma cells reverses anoikis resistance and increases sensitivity to Vemurafenib.
DOI 10.1186/s13046-026-03819-y